These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38597064)

  • 41. Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.
    Stępińska J; Marona M; Greenlaw N; Steg G;
    Kardiol Pol; 2014; 72(11):1156-64. PubMed ID: 25001472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Beta blockers in stable angina pectoris].
    Fluri M; Meier B
    Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial.
    Sawano M; Katsuki T; Kitai T; Tamita K; Obunai K; Ikegami Y; Yamane T; Ueda I; Endo A; Maekawa Y; Kawamura A; Fukuda K; Kohsaka S
    Open Heart; 2020 Oct; 7(2):. PubMed ID: 33087441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease.
    O'Rourke RA
    Am J Cardiol; 1985 Dec; 56(16):34H-40H. PubMed ID: 2866705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term beta blockers for stable angina: systematic review and meta-analysis.
    Shu de F; Dong BR; Lin XF; Wu TX; Liu GJ
    Eur J Prev Cardiol; 2012 Jun; 19(3):330-41. PubMed ID: 22779086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-anginal drugs: Systematic review and clinical implications.
    Pavasini R; Camici PG; Crea F; Danchin N; Fox K; Manolis AJ; Marzilli M; Rosano GMC; Lopez-Sendon JL; Pinto F; Balla C; Ferrari R
    Int J Cardiol; 2019 May; 283():55-63. PubMed ID: 30538056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacologic management of chronic stable angina.
    Dixit D; Kimborowicz K
    JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
    Cohn PF
    Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease.
    Pepine CJ
    Am J Med; 1986 Apr; 80(4C):25-34. PubMed ID: 2871755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Medical treatment of patients with stable angina pectoris].
    Castaigne A; Scherrer-Crosbie M; Chazouillères AF; Carville C
    Rev Prat; 1995 Nov; 45(17):2161-7. PubMed ID: 8571041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
    Mitrovic V; Miskovic A; Straub M; Beckmann K; Thormann J; Pitschner H
    Z Kardiol; 1999 Oct; 88(10):838-49. PubMed ID: 10552188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B
    Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
    Go AS; Iribarren C; Chandra M; Lathon PV; Fortmann SP; Quertermous T; Hlatky MA;
    Ann Intern Med; 2006 Feb; 144(4):229-38. PubMed ID: 16490908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.